Описание
Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.
Figure 3
ChartSource Paper
Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation.Cite This Figure
![Figure 3: Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.]() > Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)
<figure> <img src="" alt="Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function." /> <figcaption>Figure 3. Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.<br> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption> </figure>